Mistral Therapeutics, Inc. — Form D
Mistral Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-21. The offering totals $2K, of which $2K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-06-21
- Form: D
- Accession: 0001520711-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2K
- Amount sold: $2K
- Investors: 3
- Date of first sale: 2011-04-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-161542
Issuer
- Name: Mistral Therapeutics, Inc.
- CIK: 0001520711
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 5871 OBERLIN DRIVE, SAN DIEGO, CA, 92121
- Phone: (858) 224-7700
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Clare Ozawa | Director | South San Francisco, CA |
| Jerel Davis | Director | Alameda, CA |
| Bradley Bolzon | Director | SAN DIEGO, CA |
| Petpiboon Prasit | Director | San Diego, CA |
| Petpiboon Prasit | Executive Officer | San Diego, CA |
| Jeremy Caldwell | Executive Officer | Seattle, WA |
| BRADLEY J BOLZON | Director | MENLO PARK, CA |
| THOMAS A COLL | Executive Officer | SAN DIEGO, CA |
Other filings by this issuer (3)
More